Yokohama, Japan
March 28, 2016
Sakata Seed Corporation and the Indonesian government have formally agreed on the utilization of indigenous genetic resources for the further development of SunPatiens®. This agreement is based on the Convention on Biological Diversity (hereafter, CBD). There are only a few cases known in the world of such an agreement based on CBD in the category of horticultural plants, made between a resource-rich country and a commercial seed company.
SunPatiens® offered by Sakata Seed Corporation, is an assortment of garden flowers that was developed in line with the principles of CBD, in collaboration with the Indonesian Agency for Agricultural Research and Development (IAARD) for access to its native resources. SunPatiens® uses the breeding material of Indonesia’s native species of Impatiens.
In the early 2000s, IAARD and Sakata made a basic agreement for the utilization of this native species and Sakata has been conducting research and development ever since. Starting with this basic agreement, Sakata has been using Indonesian collection of genetic resources of Impatiens by applying material transfer agreement following CBD convention.
SunPatiens® was commercially launched in 2006, and has grown to be recognized worldwide as one of the best performing flowering annuals in its category, especially in Japan, Europe and North and South America. Part of the revenue generated from sales of the product is being allocated based on the agreement for Access and Benefit-Sharing for utilization of genetic resources (hereafter, ABS agreement). Sakata pays a share of the SunPatiens® royalty proceeds to the Indonesian government and, in addition, performs technology transfer as a non-monetary benefit sharing.
In 2014, the two parties updated the collaboration and implemented an innovative joint research project based on the new national measures. In 2016, both parties will continue to collaborate and will proceed with joint research of Indonesia and Sakata that will further contribute to the development of even better cooperative structures for the utilization of genetic resources and the conservation and utilization of biological diversity as an irreplaceable heritage of humankind.
References
Convention on Biological Diversity and the initiatives of Sakata Seed Corporation
In the past we have worked for developing genetic resources on the basis of the Convention on Biological Diversity. The garden plant "Mecardonia yellow chrosite" of the Scrophulariaceae family, released in November 2007, was developed by our company on the basis of the joint exploration of genetic resources by the Argentina's National Agricultural Technology Institute (INTA) and Sakata Seed Corporation. Part of the revenue from the product has been returned to Argentina based on the Agreement for Access and Benefit-Sharing of genetic resources from the Convention on Biological Diversity and helps protect the country’s biological resources.
Technological assistance to Indonesian Agency for Agricultural Research Development
In the next five years we are going to provide breeding support to the Indonesian Ornamental Crops Research Institute (IOCRI). In addition to having our breeders given lectures on breeding technology to IOCRI, the two parties are planning to conduct joint collection, evaluation and selection for the genetic resources in Indonesia. I should be noted that the company possesses preferential rights for commercialization of the new superior varieties which IOCRI obtains from our support.
About “SunPatiensⓇ”
SunPatiensⓇ, an interspecific hybrid of the Balsaminaceae family Impatiens genus, is a garden plant developed with Sakata’s breeding techniques. Currently, there are about 30 varieties sold worldwide. Its greatest features are the breakthrough growth vigor, the high heat tolerance withstanding the high temperatures and strong sunlight of summer, and the chance to enjoy a continuous bloom of vivid flowers for an extended period of time. It produces large plants of about 60cm in pot and about 1m in bedding. The extremely vivid color range includes orange, white, pink and red. Moreover, thanks to its strong roots the plant stands up to high winds and its thick petals endure wind and rain. With such features it is perfect for the garden, of course, as well as for flower beds in parks and plantings in public institutions. Since its launch in 2006, the high-performance of "SunPatiensⓇ" is receiving worldwide praise from gardening enthusiasts and landscape architects, coming from Japan, North America, Europe, and South America. With worldwide cumulative total sales exceeding 100 million plants, it is spreading around the world as a new standard for horticultural plants.
“SunPatiens Ⓡ” Awards
- “Euroflora2006” (2006, Italy): Gold Award
- “The First (2006-2007) Japan Flower Selections” (2006, Japan): Best Flower Award, etc.
- “The Second (2007-2008) Japan Flower Selections” (2007, Japan) Flower of the Year Award
- “Outstanding Varieties Competition” (2008, USA): Best in Class: Bedding Plant Award
- “Four Oaks Trade Show” (2008, United Kingdom): Best Plant Introduction Bedding or Pot Plant Award
- “Royal Horticultural Society” (2009, United Kingdom): Award of Merit
- “Euroflora 2011” (2011, Italy): most prominently FIRST PRIZE in category (Impatiens)
- “Royal Horticultural Society” (2014, United Kingdom) 4 x AGM (Award of Garden Merit)
- “Royal Horticultural Society” (2014, United Kingdom) ‘People’s Choice Award’
- “All-America Selections 2015” (2015, USA): AAS Flower Award Winner
SunPatiens: uma flor revolucionária desenvolvida pela Sakata em parceria com o Governo da Indonésia, com base nos Princípios da Convenção sobre a Diversidade Biológica
Com mais de 100 milhões de plantas vendidas no mundo inteiro, a variedade de flor SunPatiens foi criada pela empresa de sementes Sakata em parceria com governo da Indonésia
A Sakata Seed Corporation e o governo da Indonésia formalizaram um acordo internacional que resultou no desenvolvimento da flor SunPatiens, variedade que atualmente é sucesso no mundo inteiro por suas cores e fácil adaptação. A parceria, que é uma das pioneiras no mundo para a categoria de plantas floríferas ornamentais, foi baseada na Convenção sobre a Diversidade Biológica (CDB), que permitiu a utilização de recursos genéticos nativos. Atualmente existem apenas alguns casos conhecidos no mundo sobre deste tipo de acordo, realizado entre um país abundante em recursos genéticos e uma companhia comercial de sementes.
A flor foi desenvolvida pela Sakata em colaboração com a Agency for Agricultural Research and Development (IAARD) da Indonésia, utilizando recursos genéticos de espécies nativas do gênero Impatiens. Parte dos lucros obtidos com as vendas do produto são alocados de acordo com os princípios estabelecidos pela legislação de Acesso e Repartição de Benefícios (ARB) para a utilização de recursos genéticos. A Sakata paga uma parte dos royalties recebidos sobre a venda e utilização de SunPatiens para o governo da Indonésia e, em adição, transfere tecnologia como benefício compartilhado de características não monetárias, como com suporte e cursos referentes à técnicas de melhoramento para o Indonesian Ornamental Crops Research Institute (IOCRI).
Sobre a SunPatiens
Com recorde absoluto de vendas, a SunPatiens (Impatiens hybrida) tem sido reconhecida mundialmente como a melhor planta florífera ornamental em sua categoria, rendendo premiações no Japão, Estados Unidos, Itália e Reino Unido.
Desenvolvida pela Sakata Seed Corporation no Japão pelo método de melhoramento genético convencional (ou seja, sem uso de organismos geneticamente modificados), a variedade levou mais de 10 anos de pesquisa para ser criada.
Desde o seu lançamento comercial, a SunPatiens obteve a apreciação de paisagistas e entusiastas de jardinagem em todo o mundo, sobretudo na Ásia, América do Norte, Europa e América do Sul. Ao todo, são 30 variedades, que somam mais de 100 milhões de plantas vendidas pela empresa.
No Brasil, a flor já vem sendo cultivada em todas as regiões do país, pois possui grande adaptabilidade e tolerância às variações climáticas – calor intenso, chuvas e geadas leves. O seu alto vigor de planta, as cores vibrantes, a longa durabilidade e o florescimento durante o ano todo fizeram da SunPatiens uma das melhores opções para projetos paisagísticos, jardins, canteiros e vasos de parques e instituições públicas. Atualmente, a variedade já pode ser encontrada à venda nos principais centros de comercialização de flores, tais como Ceagesp, Ceasa Campinas, Veiling Holambra e Garden Centers.
Todas as variedades de SunPatiens são protegidas pela Lei Nacional de Proteção a Cultivares nº 9.456/97, Decreto 2.366/97, portanto a multiplicação é somente permitida com a autorização da Sakata. Atualmente a propagação e comercialização das mudas é feita pela Bio Plugs (Atibaia/SP) que possui a licença do detentor da genética.
Premiações da SunPatiens
- Euroflora 2006” (2006, Italy): Gold Award.
- “The First (2006-2007) Japan Flower Selections” (2006, Japan): Best Flower Award, etc.
- “The Second (2007-2008) Japan Flower Selections” (2007, Japan) Flower of the Year Award.
- “Outstanding Varieties Competition” (2008, USA): Best in Class: Bedding Plant Award.
- “Four Oaks Trade Show” (2008, United Kingdom): Best Plant Introduction Bedding or Pot Plant Award.
- “Royal Horticultural Society” (2009, United Kingdom): Award of Merit.
- “Euroflora 2011” (2011, Italy): most prominently FIRST PRIZE in category (Impatiens).
- “Royal Horticultural Society” (2014, United Kingdom) 4 x AGM (Award of Garden Merit).
- “Royal Horticultural Society” (2014, United Kingdom) “People’s Choice Award”’.
- “All America Selections 2015” (2015, USA): AAS Flower Award Winner.
Para obter mais informações sobre a SunPatiens acesse o site www.sunpatiens.com.br e, em caso de dúvidas, envie um e-mail para sunpatiens@sakata.com.br |
Topics
Species
